Commentary · 29 Nov 2025
Mini reviewPublished 27 Mar 2024
Design and Description of a New Formulation for the Transmission of the COVID-19-mRNA Vaccine to the Mucosa Nasale
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has led to a global health crisis, emphasizing the urgent need for effective vaccines. While several vaccines have been developed and are being administered worldwide, there is ongoing research to improve their efficacy and delivery methods. One promising approach is the development of a new formulation for the transmission of mRNA vaccines to the nasal mucosa, which could enhance mucosal immunity and provide additional protection against SARS-CoV-2. This article describes the design and potential benefits of such a formulation.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Bioprocessing & Biotechniques.
Commentary · 29 Nov 2025
Advancing Bioprocess Scale-Down: Technologies for Optimization
Brief report · 29 Nov 2025
Bioprocessing Sustainable Packaging Biomaterials: A Review
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioprocessing & Biotechniques
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Yue Li”
